{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T15:10:01Z","timestamp":1793286601691,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.neuropharm.2024.109939","type":"journal-article","created":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T11:08:36Z","timestamp":1711969716000},"page":"109939","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Ursolic acid molecules dock MAPK1 to modulate gut microbiota diversity to reduce neuropathic pain"],"prefix":"10.1016","volume":"252","author":[{"given":"Zi-Jie","family":"Rong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Hua","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gui-Hua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Biao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Wen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Liang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang-Fei","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2024.109939_bib1","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1080\/21655979.2021.1930925","article-title":"Knockdown of long non-coding RNA NEAT1 relieves the inflammatory response of spinal cord injury through targeting miR-211-5p\/MAPK1 axis","volume":"12","author":"An","year":"2021","journal-title":"Bioengineered"},{"key":"10.1016\/j.neuropharm.2024.109939_bib2","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/fcp.12223","article-title":"Effect of ursolic acid in attenuating chronic constriction injury-induced neuropathic pain in rats","volume":"30","author":"Bhat","year":"2016","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.109939_bib3","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.ejmech.2015.01.031","article-title":"Evolution in medicinal chemistry of ursolic acid derivatives as anticancer agents","volume":"92","author":"Chen","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2024.109939_bib4","doi-asserted-by":"crossref","first-page":"596","DOI":"10.4049\/jimmunol.1601438","article-title":"Influence of the gut microbiome on autoimmunity in the central nervous system","volume":"198","author":"Colpitts","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.neuropharm.2024.109939_bib5","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1152\/physrev.00018.2018","article-title":"The microbiota-gut-brain Axis","volume":"99","author":"Cryan","year":"2019","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2024.109939_bib6","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S1474-4422(19)30356-4","article-title":"The gut microbiome in neurological disorders","volume":"19","author":"Cryan","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2024.109939_bib7","article-title":"Sodium butyrate alleviates mouse colitis by regulating gut microbiota dysbiosis","volume":"10","author":"Dou","year":"2020","journal-title":"Animals (Basel)"},{"key":"10.1016\/j.neuropharm.2024.109939_bib8","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.neuroscience.2021.12.015","article-title":"Akt\/Aquaporin-4 signaling aggravates neuropathic pain by activating astrocytes after spinal nerve ligation in rats","volume":"482","author":"Guo","year":"2022","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2024.109939_bib9","doi-asserted-by":"crossref","first-page":"6091","DOI":"10.1039\/D0FO00829J","article-title":"Ursolic acid alleviates hypercholesterolemia and modulates the gut microbiota in hamsters","volume":"11","author":"Hao","year":"2020","journal-title":"Food Funct."},{"key":"10.1016\/j.neuropharm.2024.109939_bib10","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1038\/aps.2013.74","article-title":"Pharmacokinetic evaluation of the anticancer prodrug simmitecan in different experimental animals","volume":"34","author":"Hu","year":"2013","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.neuropharm.2024.109939_bib11","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.lfs.2016.01.017","article-title":"Ursolic acid (UA): a metabolite with promising therapeutic potential","volume":"146","author":"Kashyap","year":"2016","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2024.109939_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21165920","article-title":"Ursolic acid-based derivatives as potential anti-cancer agents: an update","volume":"21","author":"Khwaza","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2024.109939_bib13","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20190228","article-title":"Mechanism of gut microbiota and Axl\/SOCS3 in experimental autoimmune encephalomyelitis","volume":"39","author":"Li","year":"2019","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.neuropharm.2024.109939_bib14","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1590\/0004-282x20160065","article-title":"Ursolic acid attenuates beta-amyloid-induced memory impairment in mice","volume":"74","author":"Liang","year":"2016","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.neuropharm.2024.109939_bib15","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/cns.13128","article-title":"CXCL12\/CXCR4 signaling contributes to neuropathic pain via central sensitization mechanisms in a rat spinal nerve ligation model","volume":"25","author":"Liu","year":"2019","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.neuropharm.2024.109939_bib16","doi-asserted-by":"crossref","first-page":"422","DOI":"10.2174\/1389557521666210913113522","article-title":"Advances in anti-inflammatory activity, mechanism and therapeutic application of ursolic acid","volume":"22","author":"Luan","year":"2022","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.neuropharm.2024.109939_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153490","article-title":"Rosmarinic acid and ursolic acid alleviate deficits in cognition, synaptic regulation and adult hippocampal neurogenesis in an A\u03b2(1-42)-induced mouse model of Alzheimer's disease","volume":"83","author":"Mirza","year":"2021","journal-title":"Phytomedicine"},{"key":"10.1016\/j.neuropharm.2024.109939_bib18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/j.pain.0000000000001365","article-title":"The IASP classification of chronic pain for ICD-11: chronic neuropathic pain","volume":"160","author":"Scholz","year":"2019","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2024.109939_bib19","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1261\/rna.042259.113","article-title":"Splicing factor hnRNP A2 activates the Ras-MAPK-ERK pathway by controlling A-Raf splicing in hepatocellular carcinoma development","volume":"20","author":"Shilo","year":"2014","journal-title":"Rna"},{"key":"10.1016\/j.neuropharm.2024.109939_bib20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neubiorev.2014.05.002","article-title":"Modulating the delicate glial-neuronal interactions in neuropathic pain: promises and potential caveats","volume":"45","author":"Tiwari","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2024.109939_bib21","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.4103\/0366-6999.190667","article-title":"Gut microbiota-brain Axis","volume":"129","author":"Wang","year":"2016","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.neuropharm.2024.109939_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109191","article-title":"Malfunction of astrocyte and cholinergic input is involved in postoperative impairment of hippocampal synaptic plasticity and cognitive function","volume":"217","author":"Wang","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2024.109939_bib23","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/aps.2015.150","article-title":"Carbocisteine attenuates TNF-\u03b1-induced inflammation in human alveolar epithelial cells in vitro through suppressing NF-\u03baB and ERK1\/2 MAPK signaling pathways","volume":"37","author":"Wang","year":"2016","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.neuropharm.2024.109939_bib24","doi-asserted-by":"crossref","first-page":"20614","DOI":"10.3390\/molecules201119721","article-title":"Ursolic acid--A pentacyclic triterpenoid with a wide spectrum of pharmacological activities","volume":"20","author":"Wo\u017aniak","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.neuropharm.2024.109939_bib25","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/6010952","article-title":"Using network pharmacology and animal experiment to investigate the therapeutic mechanisms of polydatin against vincristine-induced neuropathic pain","volume":"2022","author":"Xi","year":"2022","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.neuropharm.2024.109939_bib26","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1159\/000495931","article-title":"MACROD1\/LRP16 enhances LPS-stimulated inflammatory responses by up-regulating a rac1-dependent pathway in adipocytes","volume":"51","author":"Zang","year":"2018","journal-title":"Cell. Physiol. Biochem."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390824001084?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390824001084?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,5]],"date-time":"2024-05-05T23:50:06Z","timestamp":1714953006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390824001084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":26,"alternative-id":["S0028390824001084"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2024.109939","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ursolic acid molecules dock MAPK1 to modulate gut microbiota diversity to reduce neuropathic pain","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2024.109939","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109939"}}